Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
04 05 2022
04 05 2022
Historique:
received:
11
11
2021
revised:
09
02
2022
accepted:
01
03
2022
pubmed:
6
3
2022
medline:
6
5
2022
entrez:
5
3
2022
Statut:
ppublish
Résumé
The Hispanic/Latino(x) population (H/L) in the United States of America is heterogeneous and fast growing. Cancer is the number one cause of death among H/Ls, accounting for 21% of deaths. Whereas for the most common cancers, incidence rates are lower in H/Ls compared with non-H/L White (NHW) individuals, H/Ls have a higher incidence of liver, stomach, cervical, penile, and gallbladder cancers. H/L patients tend to be diagnosed at more advanced stages for breast, colorectal, prostate, and lung cancers, and melanoma compared with NHW individuals. Etiologic and cancer outcomes research among H/Ls lags other populations. In this review, we provide a summary of challenges, opportunities, and research priorities related to cancer etiology, cancer outcomes, and survivorship to make progress in addressing scientific gaps. Briefly, we prioritize the need for more research on determinants of obesity, nonalcoholic fatty liver disease and its progression to liver cancer, stomach and gallbladder cancers, and pediatric acute lymphoblastic leukemia. We emphasize the need to improve cancer screening, early detection of cancer, and survivorship care. We highlight critical resources needed to make progress in cancer epidemiologic studies among H/L populations, including the importance of training the next generation of cancer epidemiologists conducting research in H/Ls.
Identifiants
pubmed: 35247883
pii: 682002
doi: 10.1158/1055-9965.EPI-21-1303
pmc: PMC9081152
mid: NIHMS1787818
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
932-941Subventions
Organisme : NCI NIH HHS
ID : P30 CA093373
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA233465
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA082103
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204797
Pays : United States
Organisme : NCI NIH HHS
ID : UG3 CA260317
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA054174
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA233444
Pays : United States
Informations de copyright
©2022 American Association for Cancer Research.
Références
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924
pubmed: 30138307
Cancer Causes Control. 2010 Oct;21(10):1721-30
pubmed: 20567897
Nat Genet. 2011 Mar;43(3):237-41
pubmed: 21297632
Br J Cancer. 2021 Jan;124(2):315-332
pubmed: 32901135
Prev Med. 2020 Dec;141:106242
pubmed: 32882299
Salud Publica Mex. 2019 Sep-Oct;61(5):601-608
pubmed: 31661737
Environ Health Perspect. 2010 Aug;118(8):1117-25
pubmed: 20444670
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):659-665
pubmed: 30914435
Contemp Clin Trials Commun. 2016 Dec 15;4:52-57
pubmed: 27570845
Am J Prev Med. 2017 Jul;53(1):e31-e33
pubmed: 28284746
Sleep Med. 2016 Feb;18:7-18
pubmed: 26431755
Nat Commun. 2014 Oct 20;5:5260
pubmed: 25327703
J Thorac Oncol. 2017 Dec;12(12):1851-1856
pubmed: 28911955
Contemp Clin Trials. 2015 Jan;40:74-80
pubmed: 25433203
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Cancer. 2016 Aug 15;122(16):2512-23
pubmed: 27195481
World J Hepatol. 2017 Mar 8;9(7):391-400
pubmed: 28321275
Arch Dermatol. 2011 Jul;147(7):863-4
pubmed: 21768492
Nat Clin Pract Oncol. 2008 Aug;5(8):466-75
pubmed: 18493231
J Glob Oncol. 2016 Mar 9;2(5):259-267
pubmed: 28717712
Ann Epidemiol. 2010 Aug;20(8):642-9
pubmed: 20609344
J Cancer Educ. 2013 Dec;28(4):729-37
pubmed: 23881820
Cancer. 2019 Aug 15;125(16):2829-2836
pubmed: 31206626
Nat Genet. 2013 Dec;45(12):1494-8
pubmed: 24141364
Ethn Dis. 2021 May 20;31(Suppl 1):283-284
pubmed: 34045828
NCHS Data Brief. 2020 Jan;(354):1-8
pubmed: 32487295
Urol Oncol. 2007 Sep-Oct;25(5):361-7
pubmed: 17826651
Health Equity. 2019 Jul 11;3(1):319-327
pubmed: 31338484
Psychooncology. 2014 May;23(5):507-15
pubmed: 24217994
J Am Acad Dermatol. 2012 May;66(5):771-9
pubmed: 21875760
CA Cancer J Clin. 2018 Nov;68(6):425-445
pubmed: 30285281
J Natl Cancer Inst. 2014 Sep 15;106(10):
pubmed: 25224496
Oncol Nurs Forum. 2005 Mar 05;32(2):250-6
pubmed: 15759063
J Infect Dis. 2018 Mar 5;217(6):869-877
pubmed: 29294016
JCO Oncol Pract. 2022 Feb;18(2):e271-e283
pubmed: 34752150
Cancer. 2014 Apr 1;120(7):955-62
pubmed: 24382716
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2162-9
pubmed: 19661072
Gastroenterology. 2017 Mar;152(4):812-820.e5
pubmed: 27889576
Qual Life Res. 2020 Oct;29(10):2615-2630
pubmed: 32430782
Lancet Oncol. 2019 Aug;20(8):1058-1059
pubmed: 31281097
Ann Intern Med. 2012 Feb 21;156(4):271-8
pubmed: 22351712
Lancet. 2017 Apr 8;389(10077):1453-1463
pubmed: 28402827
Carcinogenesis. 2016 Jun;37(6):547-556
pubmed: 27207650
J Thorac Oncol. 2015 May;10(5):838-843
pubmed: 25634006
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):405-417
pubmed: 28637795
J Health Care Poor Underserved. 2002 Nov;13(4):477-503
pubmed: 12407964
J Clin Transl Res. 2018 Apr 07;4(1):56-69
pubmed: 30873495
Aliment Pharmacol Ther. 2015 Jan;41(1):65-76
pubmed: 25376360
Cancer Causes Control. 2016 May;27(5):647-59
pubmed: 27021339
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1353-1363
pubmed: 31147314
Curr Probl Cardiol. 2019 May;44(5):148-172
pubmed: 30545650
Am J Mens Health. 2017 Jul;11(4):1039-1045
pubmed: 28413904
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642
pubmed: 30944145
Qual Life Res. 2007 Apr;16(3):413-28
pubmed: 17279444
Cancer Res. 2017 Nov 15;77(22):6462-6469
pubmed: 29141994
Sci Transl Med. 2015 Dec 23;7(319):319fs50
pubmed: 26702090
Soc Work Public Health. 2019;34(7):606-615
pubmed: 31370744
Leukemia. 2013 Dec;27(12):2416-9
pubmed: 23615557
Am J Public Health. 2015 Dec;105(12):e60-76
pubmed: 26469668
JCO Oncol Pract. 2020 Sep;16(9):e922-e932
pubmed: 32384017
J Health Dispar Res Pract. 2020 Spring;13(1):50-66
pubmed: 34221702
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2
pubmed: 23041539
J Immigr Minor Health. 2018 Aug;20(4):823-830
pubmed: 28752364
Prev Med. 2021 Mar;144:106400
pubmed: 33388330
N Engl J Med. 2021 Feb 25;384(8):768-773
pubmed: 33326717
Am J Public Health. 2015 Nov;105(11):2341-8
pubmed: 26378826
PLoS Med. 2006 Feb;3(2):e19
pubmed: 16318411
J Clin Epidemiol. 2019 Apr;108:34-43
pubmed: 30529005
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2
pubmed: 28970148
Nutr J. 2019 Jun 26;18(1):32
pubmed: 31242913
Oncology (Williston Park). 2021 Mar 15;35(3):107
pubmed: 33818053
Am J Epidemiol. 2000 Feb 15;151(4):346-57
pubmed: 10695593
J Toxicol Environ Health B Crit Rev. 2012;15(4):238-63
pubmed: 22571220
Cancer Causes Control. 2011 Apr;22(4):553-61
pubmed: 21279543
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
Public Health Rep. 2001 Sep-Oct;116(5):404-16
pubmed: 12042604
Am J Epidemiol. 2007 Jul 1;166(1):46-54
pubmed: 17400570
J Cancer Surviv. 2009 Dec;3(4):212-22
pubmed: 19760151
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
MMWR Surveill Summ. 2017 May 05;66(11):1-28
pubmed: 28472027
Oncologist. 2021 Jun;26(6):443-452
pubmed: 33594785
Lancet Oncol. 2013 Dec;14(13):1262-3
pubmed: 25035875
Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):3-10
pubmed: 29054978
J Immigr Minor Health. 2017 Feb;19(1):108-119
pubmed: 26895151
Dig Dis Sci. 2020 Aug;65(8):2403-2411
pubmed: 31728790
Int J Epidemiol. 2017 Apr 1;46(2):e3
pubmed: 25747868
Carcinogenesis. 2012 Nov;33(11):2108-18
pubmed: 22822096
Am J Health Behav. 2019 Jul 1;43(4):802-811
pubmed: 31239022
J Oncol Pract. 2015 Sep;11(5):396-402
pubmed: 26286100
Cancer. 2008 Sep 1;113(5):1058-67
pubmed: 18618494
Cancer. 2016 May 1;122(9):1444-52
pubmed: 26916271
Clin Gastroenterol Hepatol. 2019 Feb;17(3):429-439
pubmed: 29902641
Support Care Cancer. 2019 Apr;27(4):1383-1394
pubmed: 30136022
Lancet Oncol. 2015 Dec;16(16):1599-600
pubmed: 26514947
Am Soc Clin Oncol Educ Book. 2016;35:185-98
pubmed: 27249699
Genes (Basel). 2019 Feb 18;10(2):
pubmed: 30781715
Cancer Res. 2020 May 1;80(9):1893-1901
pubmed: 32245796
Cancer Res. 2008 Dec 1;68(23):9723-8
pubmed: 19047150
Perspect Biol Med. 2003 Summer;46(3 Suppl):S39-52
pubmed: 14563073
Cancer. 2013 Aug 15;119(16):2956-63
pubmed: 23674318
Cancer. 2020 Mar 1;126(5):1077-1089
pubmed: 31909824
J Natl Cancer Inst. 2020 Jun 1;112(6):590-598
pubmed: 31553449
Am J Prev Med. 2018 Aug;55(2):197-204
pubmed: 29859731
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3106-18
pubmed: 20940276
Rev Panam Salud Publica. 2009 May;25(5):394-400
pubmed: 19695128
JAMA Oncol. 2016 Aug 1;2(8):1070-4
pubmed: 27366979
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):376-382
pubmed: 28223429
Cancer. 2016 Sep 15;122(18):2867-75
pubmed: 27351365
BMJ. 2021 Mar 16;372:n365
pubmed: 33727242
Adv Cancer Res. 2017;133:77-94
pubmed: 28052822
Cancer Causes Control. 2005 Aug;16(6):713-23
pubmed: 16049810
Curr Epidemiol Rep. 2016;3:181-190
pubmed: 27547694
AIMS Public Health. 2017;4(5):526-556
pubmed: 29333472
Hum Genomics. 2019 Feb 20;13(1):12
pubmed: 30786938
CA Cancer J Clin. 2021 Nov;71(6):466-487
pubmed: 34545941
J Cancer Educ. 2019 Dec;34(6):1112-1119
pubmed: 30112612